Caption Management’s Phibro Animal Health PAHC Stock Holding History

Caption Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$2.14K	–	1781
2025 Q1	$2.14K	Buy	+100	New	+$2.23K	﹤0.01%	1434

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caption Management's PAHC Position: Q2 2025 in Review

Caption Management sold out of Phibro Animal Health (PAHC) in Q2 2025, closing a stake of 100 shares — an estimated $2.14K sold.

Caption Management first reported a position in PAHC in Q1 2025 and held it in 1 quarter. The position peaked at $2.14K in Q1 2025. 194 funds tracked by Wall St. Rank hold PAHC as of Q2 2025.

Caption Management reported no remaining Phibro Animal Health position as of Q2 2025 after selling out during the quarter.
Caption Management sold 100 Phibro Animal Health shares in Q2 2025, an estimated $2.14K.
Caption Management first reported a position in Phibro Animal Health in Q1 2025 and held it in 1 quarter.
Caption Management's Phibro Animal Health position peaked at $2.14K in Q1 2025.
194 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.